Ruixia Ma

1.2k total citations
51 papers, 819 citations indexed

About

Ruixia Ma is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Ruixia Ma has authored 51 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 13 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Ruixia Ma's work include Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (6 papers) and Autophagy in Disease and Therapy (6 papers). Ruixia Ma is often cited by papers focused on Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (6 papers) and Autophagy in Disease and Therapy (6 papers). Ruixia Ma collaborates with scholars based in China, United States and Bulgaria. Ruixia Ma's co-authors include Yaguang Xi, Hong Chang, Hongyou Zhao, Bin Yi, Xiaoguo Zhang, Liqiu Liu, Xuemei Liu, Congjuan Luo, Wei Jiang and Huifang Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Ruixia Ma

48 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixia Ma China 15 379 232 209 102 80 51 819
Qifeng Liu China 19 236 0.6× 296 1.3× 47 0.2× 137 1.3× 65 0.8× 56 758
Jun Shi China 16 560 1.5× 93 0.4× 306 1.5× 96 0.9× 70 0.9× 39 817
Xue Hong China 17 468 1.2× 343 1.5× 80 0.4× 129 1.3× 97 1.2× 31 973
Jinzhuo Ning China 19 669 1.8× 113 0.5× 383 1.8× 106 1.0× 103 1.3× 68 1.1k
Minseob Eom South Korea 14 352 0.9× 104 0.4× 121 0.6× 89 0.9× 69 0.9× 45 797
Samuel Mon-Wei Yu United States 15 357 0.9× 210 0.9× 97 0.5× 172 1.7× 186 2.3× 34 830
Zhengwei Ma China 13 348 0.9× 183 0.8× 118 0.6× 77 0.8× 57 0.7× 17 702
Mark DeNichilo Australia 16 677 1.8× 183 0.8× 108 0.5× 60 0.6× 175 2.2× 25 1.2k
Dickson W.L. Wong Germany 14 254 0.7× 192 0.8× 43 0.2× 107 1.0× 286 3.6× 27 867
Jian Han China 16 293 0.8× 57 0.2× 138 0.7× 47 0.5× 117 1.5× 31 756

Countries citing papers authored by Ruixia Ma

Since Specialization
Citations

This map shows the geographic impact of Ruixia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixia Ma more than expected).

Fields of papers citing papers by Ruixia Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixia Ma. The network helps show where Ruixia Ma may publish in the future.

Co-authorship network of co-authors of Ruixia Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixia Ma. A scholar is included among the top collaborators of Ruixia Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixia Ma. Ruixia Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Yan, et al.. (2024). The multifaceted effects of mitochondria in kidney diseases. Mitochondrion. 79. 101957–101957. 1 indexed citations
3.
Li, Li, Hui Yang, Bin Zou, et al.. (2024). Therapeutic effect of nicotinamide mononucleotide on Alzheimer’s disease through activating autophagy and anti-oxidative stress. Biomedicine & Pharmacotherapy. 178. 117199–117199. 12 indexed citations
4.
Liu, Qi, et al.. (2024). Comparative analysis of forest soil carbon sink and source based on bibliometrics: Development, hotspots, and trends. Journal of Cleaner Production. 480. 144106–144106. 3 indexed citations
5.
Zhang, Yao, Jingjing Zhu, Yan Zhou, et al.. (2024). Activation of HIF-1α C-terminal transactivation domain promotes tubulointerstitial fibrosis through hexokinase 2-mediated metabolic reprogramming. Cellular Signalling. 127. 111531–111531. 1 indexed citations
6.
Chai, Rong, et al.. (2024). Different strategies for treating intracanal fractured instruments in a single tooth: A case report. Experimental and Therapeutic Medicine. 28(5). 411–411.
7.
Zhou, Yan, et al.. (2023). Loss of Sirt1 promotes exosome secretion from podocytes by inhibiting lysosomal acidification in diabetic nephropathy. Molecular and Cellular Endocrinology. 568-569. 111913–111913. 6 indexed citations
8.
Zhou, Yan, Congcong Liu, Aiqing Zhang, et al.. (2023). Tubular TMEM16A promotes tubulointerstitial fibrosis by suppressing PGC-1α-mediated mitochondrial homeostasis in diabetic kidney disease. Cellular and Molecular Life Sciences. 80(12). 347–347. 9 indexed citations
9.
Ma, Ruixia, et al.. (2023). Development and validation of a prognostic nomogram for the renal relapse of lupus nephritis. Medicina Clínica. 161(7). 277–285. 1 indexed citations
10.
Li, Zuo‐Lin, et al.. (2022). Long noncoding RNA SNHG5 promotes podocyte injury via the microRNA-26a-5p/TRPC6 pathway in diabetic nephropathy. Journal of Biological Chemistry. 298(12). 102605–102605. 11 indexed citations
11.
Wang, Mengyu, Jia Liu, Wenbin Fu, et al.. (2022). Mapping of lumbar multifidus stiffness Quantification in ankylosing spondylitis with shear-wave elastography. BMC Musculoskeletal Disorders. 23(1). 917–917. 3 indexed citations
12.
Li, Jing, et al.. (2022). Gold Nanorods-Based Photothermal Therapy: Interactions Between Biostructure, Nanomaterial, and Near-Infrared Irradiation. Nanoscale Research Letters. 17(1). 68–68. 49 indexed citations
13.
Xu, Jimin, Hye-Jin Kim, Haiying Chen, et al.. (2022). Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents. European Journal of Medicinal Chemistry. 234. 114229–114229. 1 indexed citations
14.
Ma, Ruixia, Zhijiang Liang, Xiaomei Shi, et al.. (2021). Exosomal miR-486-5p derived from human placental microvascular endothelial cells regulates proliferation and invasion of trophoblasts via targeting IGF1. Human Cell. 34(5). 1310–1323. 25 indexed citations
16.
Liu, Xuemei, Huifang Wang, Ruixia Ma, et al.. (2018). The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3–5. Clinical and Experimental Nephrology. 23(3). 362–370. 26 indexed citations
17.
Wang, Tong, Ruixia Ma, & Guohua Wu. (2016). Tacrolimus protects podocytes by up-regulating autophagy in type 2 diabetic model rats. 32(3). 195–199. 1 indexed citations
18.
Ma, Ruixia, Yan Xu, Juan Zhang, Yushan Li, & Liqiu Liu. (2012). [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].. PubMed. 51(2). 117–22. 3 indexed citations
19.
Ma, Ruixia, Xuemei Liu, & Liqiu Liu. (2010). Effects of triptolide on the podocyte protein expression of Nephrin and Podocin and its mechanism in type 2 diabetic rats. 2(4). 291–296. 2 indexed citations
20.
Ma, Ruixia, et al.. (2009). Effect of Triptolide on podocyte injury and its mechanism in the kidney of 2 type diabetic rats. Zhongguo mianyixue zazhi. 25(5). 404–408. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026